Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,846,543 shares of BIO stock, worth $507 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,846,543
Previous 1,912,157
3.43%
Holding current value
$507 Million
Previous $466 Million
4.32%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding BIO
# of Institutions
427Shares Held
19.1MCall Options Held
10.7KPut Options Held
37.5K-
First Eagle Investment Management, LLC2.52MShares$692 Million1.23% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$426 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$275 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$237 Million2.27% of portfolio
-
Ariel Investments, LLC Chicago, IL819KShares$225 Million2.51% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.77B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...